Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: A randomised controlled trial in healthy elderly adults
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference37 articles.
1. Antithrombotic therapy for venous thromboembolic disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition);Kearon;Chest,2008
2. Antithrombotic therapy in atrial fibrillation: American college of chest physicians evidence-based clinical practice guidelines (8th edition);Singer;Chest,2008
3. Pharmacology and management of the vitamin k antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th edition);Ansell;Chest,2008
4. Parenteral anticoagulants: American college of chest physicians evidence-based clinical practice guidelines (8th edition);Hirsh;Chest,2008
5. American College of Chest P. Antithrombotic and thrombolytic therapy: American college of chest physicians evidence-based clinical practice guidelines (8th edition);Hirsh;Chest,2008
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical use of thrombin generation assays;Journal of Thrombosis and Haemostasis;2021-10-08
2. Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine;Journal of Thrombosis and Haemostasis;2021-09-26
3. Comparisons of Edoxaban Versus Warfarin on Levels of Plasma Prothrombin Fragment in Patients With Nonvalvular Atrial Fibrillation;The American Journal of Cardiology;2020-12
4. The Efficacy and Safety of Edoxaban versus Warfarin in Prevention of Clinical Events in Atrial Fibrillation: A Systematic Review and Meta-analysis;The Anatolian Journal of Cardiology;2020
5. Determination of edoxaban equivalent concentrations in human plasma by an automated anti-factor Xa chromogenic assay;Thrombosis Research;2017-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3